๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-01-15

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH) (NCT05238519)

๐Ÿ”ต Active, Not Recruiting Phase3 ๐Ÿง  Behavioral & Psychological Program Sponsor: Essentia Health

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to receive usual care or motivational interview. Primary study outcomes include knowledge of FH, as well as clinical and patient-reported outcomes. This study aims to promote optimal disease management and improve outcomes of FH patients.

Who can join: Review the eligibility criteria below.

Location: Aspirus St. Luke's Hospital โ€” Duluth, Minnesota

Age range: 2 Years to 75 Years

๐Ÿงช Interventions in This Study

  • Motivational interview (MI) (BEHAVIORAL)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (2 Sites)

  • Aspirus St. Luke's Hospital โ€” Duluth, Minnesota
  • Essentia Health โ€” Duluth, Minnesota

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—